Chapter 78 HKUST New Venture Fund
"Xiao Xu, are you going to set up a company?"
In the office.
Hearing Tian Liangwei's words, Xu Yun was stunned subconsciously.
But soon, he nodded calmly:
"That's right."
Xu Yun's answer was as expected by Tian Liangwei. After all, the commercial value of fifth-generation imidacloprid is there, and even interstellar players can see its prospects.
Then Tian Liangwei thought for a while, motioned Xu Yun to sit down, and said:
"So Xiao Xu, do you have any ideas about the company's preparations?"
Xu Yun didn't say anything after hearing this. He picked up the tea cup and took a sip, then looked at his teacher.
A few seconds passed.
They both laughed at the same time.
Xu Yun smiled while pouring a cup of tea for Tian Liangwei and said:
“Teacher, don’t forget, HKUST still holds 30% of the patent rights for the fifth generation imidacloprid.
The school will not give up on me, and I cannot leave our school.
So don’t test me, just tell me what the school’s plans are. ”
As a member of HKUST for nearly 20 years, Xu Yun’s feelings for HKUST naturally needless to say.
Human beings are not grass and trees, how can they be ruthless?
Even though he later left his job and went to work, his relationship remained with HKUST, and he would go back to school during holidays to visit his teachers and classmates.
At the same time, from a rational perspective, HKUST is undoubtedly an excellent partner.
Xu Yun's current situation is that he has technology but lacks funds.
Of course.
Funds here refer to big money.
For example, he has more than 60,000 yuan saved over the years in his Alipay, but under the current circumstances, 60,000 yuan can basically not make much trouble.
Therefore, his only option was to find institutional cooperation.
It is nothing more than official, private, or even overseas institutions, or some vampire-like venture capital or private equity funds.
Among all the alternatives, HKUST is superior to the others in almost every aspect.
First of all, HKUST is backed by the Academy of Sciences, and there are many top academician-level talents in the school.
Regardless of status or background, he can be called a local giant.
Secondly, HKUST has rich experience in corporate investment and management. It has multiple directly affiliated investment institutions and a vast business territory.
Of course.
HKUST is not the only one doing this when universities engage in industry; almost all colleges and universities at home and abroad are currently taking this path.
For example, the famous Harvard even established an alumni investment fund to directly purchase private equity bonds.
Stanford University has established a number of venture capital institutions, investing in more than 300 projects a year.
In recent years, it has covered the country of stealing, and it is estimated that it will touch the mainland in a while.
It can be said that today's colleges and universities are no longer the academic-only places that many people think of.
After all, many people can’t make a living just by engaging in academics. In the future, universities will be positioned as mature industry-university-research modules, which is an inevitable trend.
For example, Shuimu is currently a shareholder of 14 listed companies, and the market values of 000938 and 002049 under his name are more than 60 billion.
The representative of the University of Science and Technology is 688027, with a market value of more than 20 billion.
This mature business management system is undoubtedly a huge help to Xu Yun today - you can ask him to do scientific research or write papers, but when it comes to business management, Xu Yun is completely half-baked.
The most recent example is Morishita Pharmaceutical's trial a few hours ago.
Are Morishita Pharmaceutical's practices disgusting?
The answer is obvious.
But from a business perspective, it was indeed an operation that Xu Yundu admired.
And behind this kind of operation, there must be an expert who knows this well to give guidance.
If you ask Xu Yun to find experts of this level, you may happen to bump into one or two through the alumni circle, but it is almost impossible to organize a complete company operating system.
That being the case, why not leave this worry to someone else?
On the other hand, HKUST is obviously not willing for Xu Yun to seek cooperation with outsiders - this is like an intrusion by her husband. It is clearly his own thing, so why should he give others a share of the pie?
Both parties have related demands and emotional foundations.
Then cooperation is naturally a win-win move.
Tian Liangwei then made a phone call and communicated with someone for several minutes.
Half an hour later.
A middle-aged man in his thirties with a mustache and a suit came to the office.
Wang Qingchen took Chang Licheng to say goodbye and left.
"Xiao Xu, let me introduce you."
Tian Liangwei welcomed the middle-aged man into the office and introduced:
"This is Mr. Zheng Zu, the general person in charge of investment at HKUST and secretary-general of HKUST New Venture Fund."
Xu Yun shook hands with Zheng Zuyi politely:
"Hello, Secretary-General Zheng."
As a veteran who has been at HKUST for many years, Xu Yun has naturally heard of Zheng Zu’s name.
Generally speaking.
The general person in charge of a fund is often the chairman, and the secretary-general is the full-time auxiliary core.
However, university funds are different. The chairman of university venture capital funds is generally held concurrently by the school director, who acts like a business card. The actual person in charge is the secretary-general.
As the saying goes, everyone carries the sedan chair. Xu Yun was so polite, and Zheng Zu naturally seemed very enthusiastic:
"Hello, hello, I've heard about Xu Shen's name for a long time. When I saw him today, he was really a young man with extraordinary talent. He was only eight months old when he climbed to the top of the mountain."
He started with two lines of poetry, and the secretary-general seemed to be an old literary youth.
After the business exchange was over, Tian Liangwei first notified the insider to set his office status as not accepting customers for the time being. Then he led Xu Yun and Zheng Zu to the coffee table and started talking:
"Xiao Xu, Lao Zheng, since both of us have intentions, let's just decide on the framework first. What are your intentions?"
When Xu Yun heard this, he subconsciously looked at Zheng Zu and said in unison:
"I'm fine."
"Very good."
Tian Liangwei nodded and said to Zheng Zu:
"Mr. Zheng, then it's up to you to introduce me."
Zheng Zu turned his body slightly to one side, put his left elbow on the armrest of the sofa, and put his right hand on his left wrist as if to feel his pulse:
"Dr. Xu and Academician Tian must all know that when setting up a company, the most important issue is equity distribution.
Generally speaking, the shares held when a company is founded are divided according to the amount of investment.
For example, if the registered capital is one million, A's contribution of 300,000 will account for 30%, and B's contribution of 100,000 will account for 10%.
However, Xiao Xu, your situation is quite special, so the fund’s advice is to let you invest through technology. ”
After Xu Yun listened to Zheng Zu's introduction quietly, he nodded slightly, indicating that he had no problem.
Technology investment is also called technology partner.
In real life, the biggest problem with this type of collaborator is that they may be taken seriously in the early stage but kicked out later.
However, Xu Yun is not worried about this situation - most of the so-called "technical shares" of the kicked-out technical partners are not actually intellectual property rights in the true sense.
Real intellectual property rights are formal rights and interests protected by Article 27 of the Company Law. Especially for university incubation funds such as the HKUST New Venture Fund, the legal framework is more restrictive.
In addition, although there have been some disputes among companies under HKUST, these were mainly due to disagreements within the framework.
For example, in terms of personnel appointments, R&D fund allocation, etc., we have never been kicked out in violation of the rules because of technology investment.
Then Xu Yun thought for a while and said:
“Secretary-General Zheng, it’s okay to invest in technology, but I also have a request.”
Zheng Zu and Tian Liangwei looked at each other:
"You said."
"The first product of the company we are going to build will definitely be the fifth generation imidacloprid, right?"
"Of course."
"So if I continue to break through the inherent barriers of other technologies in the future, how should these profits be distributed?" (End of Chapter)